Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Voyager Therapeutics Inc (VYGR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Voyager Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.360 +0.540    +6.91%
01/05 - Closed. Currency in USD ( Disclaimer )
After Hours
8.500
+0.140
+1.675%
0:59:16 - Real-time Data
  • Volume: 606,323
  • Bid/Ask: 8.420 / 8.500
  • Day's Range: 7.800 - 8.547
Type:  Equity
Market:  United States
Voyager Therapeutics Inc 8.360 +0.540 +6.91%

Voyager Therapeutics Inc Company Profile

 
Read the Voyager Therapeutics Inc company profile to learn more about the business and the management team. View Voyager Therapeutics Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

162

Equity Type

ORD

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company’s lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer’s disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer’s disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer’s disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich’s ataxia; and GBA1 gene replacement to treat parkinson’s disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington’s disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Contact Information

Address 75 Hayden Avenue
Lexington, 02421
United States
Phone 857 259 5340
Fax -

Top Executives

Name Age Since Title
Michael J. Higgins 62 2015 Independent Chairman of the Board
Glenn F. Pierce 68 2017 Independent Director
James Arthur Geraghty 70 2014 Independent Director
Steven E. Hyman 72 2015 Independent Director
Alfred W. Sandrock 66 2022 President, CEO & Director
Nancy Vitale 53 2020 Independent Director
Grace E. Colon 57 2023 Independent Director
Catherine J. Mackey 69 2022 Independent Director
Dinah Sah 63 2014 Consultant & Member of Scientific Advisory Board
George A. Scangos 76 2023 Director
Phillip D. Zamore - - Founder & Member of Scientific Advisory Board
Jude Onyia 60 2023 Director
Guangping Gao - - Founder & Member of Scientific Advisory Board
David Liu - - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VYGR Price Commentary

Write your thoughts about Voyager Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Rollings
John Rollings Nov 29, 2021 17:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Major Alalyst sets share price to be $12 bargain of a share !
John Rollings
John Rollings Nov 19, 2021 17:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WOW PREVENTION OF CANCER JUST ANOUNCED !!!
John Rollings
John Rollings Nov 03, 2021 19:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ideal for aquisition by Pfizer ! SP is a massive BUY !
John Rollings
John Rollings Oct 25, 2021 20:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Notification of HUGE BUY of  3,557,507 shares listed on the SEC today !
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email